CA2253078A1 - Composition immunologique et sa methode d'utilisation pour provoquer une demyelinisation transitoire dans le systeme nerveux central d'un mammifere afin de favoriser la regeneration des neurones - Google Patents

Composition immunologique et sa methode d'utilisation pour provoquer une demyelinisation transitoire dans le systeme nerveux central d'un mammifere afin de favoriser la regeneration des neurones

Info

Publication number
CA2253078A1
CA2253078A1 CA 2253078 CA2253078A CA2253078A1 CA 2253078 A1 CA2253078 A1 CA 2253078A1 CA 2253078 CA2253078 CA 2253078 CA 2253078 A CA2253078 A CA 2253078A CA 2253078 A1 CA2253078 A1 CA 2253078A1
Authority
CA
Canada
Prior art keywords
nervous system
central nervous
immunological composition
neuronal regeneration
mammalian central
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2253078
Other languages
English (en)
Other versions
CA2253078C (fr
Inventor
John D. Steeves
Jason K. Dyer
Hans S. Keirstead
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2219683 external-priority patent/CA2219683A1/fr
Application filed by Individual filed Critical Individual
Priority to CA 2253078 priority Critical patent/CA2253078C/fr
Publication of CA2253078A1 publication Critical patent/CA2253078A1/fr
Application granted granted Critical
Publication of CA2253078C publication Critical patent/CA2253078C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2253078 1997-10-28 1998-10-28 Composition immunologique et sa methode d'utilisation pour provoquer une demyelinisation transitoire dans le systeme nerveux central d'un mammifere afin de favoriser la regeneration des neurones Expired - Fee Related CA2253078C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2253078 CA2253078C (fr) 1997-10-28 1998-10-28 Composition immunologique et sa methode d'utilisation pour provoquer une demyelinisation transitoire dans le systeme nerveux central d'un mammifere afin de favoriser la regeneration des neurones

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CA 2219683 CA2219683A1 (fr) 1997-10-28 1997-10-28 Composition immunologique et methodes d'utilisation pour perturber transitoirement la myelin au systeme nerveux central de mammiferes pour promouvoir la regeneration des neuronnes
CA2,251,410 1998-10-16
CA2251410 1998-10-16
CA2,219,683 1998-10-16
CA 2253078 CA2253078C (fr) 1997-10-28 1998-10-28 Composition immunologique et sa methode d'utilisation pour provoquer une demyelinisation transitoire dans le systeme nerveux central d'un mammifere afin de favoriser la regeneration des neurones

Publications (2)

Publication Number Publication Date
CA2253078A1 true CA2253078A1 (fr) 1999-04-28
CA2253078C CA2253078C (fr) 2001-05-01

Family

ID=27170505

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2253078 Expired - Fee Related CA2253078C (fr) 1997-10-28 1998-10-28 Composition immunologique et sa methode d'utilisation pour provoquer une demyelinisation transitoire dans le systeme nerveux central d'un mammifere afin de favoriser la regeneration des neurones

Country Status (1)

Country Link
CA (1) CA2253078C (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7285415B2 (en) 2002-07-11 2007-10-23 The Regents Of The University Of California Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
US7579188B2 (en) 2002-07-11 2009-08-25 The Regents Of The University Of California Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
US8513009B2 (en) 2008-01-30 2013-08-20 Geron Corporation Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells
CN115282277A (zh) * 2015-11-20 2022-11-04 纪念斯隆-凯特琳癌症中心 调节血液脑脊髓液屏障的通透性

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7285415B2 (en) 2002-07-11 2007-10-23 The Regents Of The University Of California Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
US7579188B2 (en) 2002-07-11 2009-08-25 The Regents Of The University Of California Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
EP2273268A2 (fr) 2002-07-11 2011-01-12 The Regents of The University of California Oligodendrocytes dérivés de cellules souches embryonnaires humaines pour remyélinisation et traitement de lésion de la moelle épinière
US10611998B2 (en) 2002-07-11 2020-04-07 The Regents Of The University Of California Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
US8513009B2 (en) 2008-01-30 2013-08-20 Geron Corporation Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells
CN115282277A (zh) * 2015-11-20 2022-11-04 纪念斯隆-凯特琳癌症中心 调节血液脑脊髓液屏障的通透性

Also Published As

Publication number Publication date
CA2253078C (fr) 2001-05-01

Similar Documents

Publication Publication Date Title
DE60042785D1 (de) Immuntherapie von autoimmunerkrankungen durch die verwendung von b-zell spezifischen antikörpern
EP1970386A8 (fr) Immunoglobulines hybrides
ATE248605T1 (de) Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper
EP0346087A3 (fr) Anticorps hybride et procédé pour sa production
DE69020143T2 (de) Verfahren zur verwendung und herstellung von peptiden.
CA2128511A1 (fr) Proteines de fusion comportant des fragments d'anticorps monomeriques et dimeriques
EP1808155A3 (fr) Hybrides de protéines de sérum d'anticorps
IL135799A0 (en) Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration
WO1995027059A1 (fr) L'afamine, une proteine albuminoide serique humaine
CA2253078A1 (fr) Composition immunologique et sa methode d'utilisation pour provoquer une demyelinisation transitoire dans le systeme nerveux central d'un mammifere afin de favoriser la regeneration des neurones
CA2071211A1 (fr) Dosages immunologiques pour les peptides de l'activation de la prothrombine, anticorps monoclonaux diriges contre eux et leurs produits de degradation
DE3660885D1 (en) Catalyst for the isomerisation of fractions rich in normal paraffins
BR9712575A (pt) Processo para restaurar em células que apresentam uma proteìna p53 que sofreu mutação , uma atividade de transactivação p53-dependente, utilizações de um anticorpo de cadeia simples capaz de ligar especificamente uma proteìna p53 que sofreu mutação, e de um ácido nucleico codificante, molécula 11d3 ou uma variante, ácido nucleico e composição
WO1999025734A3 (fr) APPAUVRISSEMENT DE LA CELLULE Th2, COMPOSITIONS ET METHODES EN RAPPORT
BR9101117A (pt) Produto que compreende um ou mais veiculos de material enzimatico e processo para distribuir um agente ativo a um sitio
CA2154013A1 (fr) Element d'analyse, composition et methode faisant appel a l'apoperoxydase de raifort
EP0149486A3 (fr) Détergents et composition de carburant les contenant
ZA9710964B (en) Synthetic biepitope compounds which can be used as standards in the biological assays of troponin I
ATE110469T1 (de) Nichttrennender festphasen-enzymtest.
FR2441212A1 (fr) Pedale pour vehicules
Stolinsky et al. ON THE UNIVALENT FRAGMENTS OF HUMAN 7 S GAMMA-GLOBULIN.
EP0806478A3 (fr) Protéine p53as et anticorps correspondant
BR8904681A (pt) Uma linha de celulas de hibridoma,mutantes,anticorpos,processos para a preparacao de uma linha de celulas e para a preparacao de anticorpos e processo e agente para comprovacao imunologica de atrazina
Power et al. Corporate profile
CA2148689A1 (fr) Traitement de l'infertilite et accroissement de la capacite de fertilisation chez des mammiferes males

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20131029